Abstract:Although myocyte cell transplantation studies have suggested a promising therapeutic potential for myocardial infarction, a major obstacle to the development of clinical therapies for myocardial repair is the difficulties associated with obtaining relatively homogeneous ventricular myocytes for transplantation. Human embryonic stem cells (hESCs) are a promising source of cardiomyocytes. Here we report that retinoid signaling regulates the fate specification of atrial versus ventricular myocytes during cardiac differentiation of hESCs. We found that both Noggin and the pan-retinoic acid receptor antagonist BMS-189453 (RAi) significantly increased the cardiac differentiation efficiency of hESCs. To investigate retinoid functions, we compared Noggin+RAi-treated cultures with Noggin+RA-treated cultures. Our results showed that the expression levels of the ventricular-specific gene IRX-4 were radically elevated in Noggin+RAi-treated cultures. MLC-2V, another ventricular-specific marker, was expressed in the majority of the cardiomyocytes in Noggin+RAi-treated cultures, but not in the cardiomyocytes of Noggin+RA-treated cultures. Flow cytometry analysis and electrophysiological studies indicated that with 64.7 ± 0.88% (mean ±s.e.m) cardiac differentiation efficiency, 83% of the cardiomyocytes in Noggin+RAi-treated cultures had embryonic ventricular-like action potentials (APs). With 50.7 ± 1.76% cardiac differentiation efficiency, 94% of the cardiomyocytes in Noggin+RA-treated cultures had embryonic atrial-like APs. These results were further confirmed by imaging studies that assessed the patterns and properties of the Ca(2+) sparks of the cardiomyocytes from the two cultures. These findings demonstrate that retinoid signaling specifies the atrial versus ventricular differentiation of hESCs. This study also shows that relatively homogeneous embryonic atrial- and ventricular-like myocyte populations can be efficiently derived from hESCs by specifically regulating Noggin and retinoid signals.

Expression Pattern of Muscarinic Receptors in Mouse Embryonic Stem Cell-derived Cardiomyocytes

Mouse Embryonic Stem Cell-Derived Cardiomyocytes Express Functional Adrenoceptors.

[Expression of Metabotropic Glutamate Receptor 4 in Cardiomyocytes Differentiated from Mouse Embryonic Stem Cells in Vitro].

Time-dependence of Cardiomyocyte Differentiation Disturbed by Peroxisome Proliferator-Activated Receptor Α Inhibitor GW6471 in Murine Embryonic Stem Cells in Vitro

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

The Expression of Calcium-Sensing Receptor in Mouse Embryonic Stem Cells (mescs) and Its Influence on Differentiation of Mesc into Cardiomyocytes.

Beta-adrenergic Signals Regulate Cardiac Differentiation of Mouse Embryonic Stem Cells Via Mitogen-Activated Protein Kinase Pathways.

Icariin Promotes Expression of Junctophilin 2 and Ca2+ Related Function During Cardiomyocyte Differentiation of Murine Embryonic Stem Cells.

Peroxisome proliferator-activated receptor alpha is involved in cardiomyocyte differentiation of murine embryonic stem cells in vitro.

Establishment of Murine Embryonic Stem Cell Line Carrying Enhanced Green Fluorescence Protein and Its Differentiation into Cardiomyocyte-like Cells in Vitro

Involvement of Metabotropic Glutamate Receptor 5 in Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells.

Icariin-mediated Expression of Cardiac Genes and Modulation of Nitric Oxide Signaling Pathway During Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes in Vitro.

Icariin Promotes Expression of PGC-1α, PPARα, and NRF-1 During Cardiomyocyte Differentiation of Murine Embryonic Stem Cells in Vitro

Cyclic adenosine 3',5'-monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes.

Involvement of p38MAPK and reactive oxygen species in icariin-induced cardiomyocyte differentiation of murine embryonic stem cells in vitro.

Cyclic adenosine 3 0 ,5 0 -monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

Inducible Effects of Icariin, Icaritin, and Desmethylicaritin on Directional Differentiation of Embryonic Stem Cells into Cardiomyocytes in Vitro

[Expression of Junctophilin 1 during cardiogenesis of mouse embryonic stem cells and rat embryos].

Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line

Involvement Of Rictor/Mtorc2 In Cardiomyocyte Differentiation Of Mouse Embryonic Stem Cells In Vitro